Eisai: Clinical Trials & Research Profile

Biopharma Industry (Tokyo, JP / Nutley, NJ) · Primary Focus: Neurology, Psychiatry, and Pain

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Tokyo, JP / Nutley, NJ)
Primary Therapeutic AreaNeurology, Psychiatry, and Pain
Active Phase II & III Studies9 active (3 recruiting now)
Total Tracked Studies (2018 to 2026)31 (17 with California sites)
Completed vs Early-Stopped Studies18 completed / 4 stopped (12.9% stop rate)
Median Closed Enrollment53 participants
FDA Drugs@FDA Original Approvals15 all-time (3 from 2018 to 2026)
Physical Hospital Site Disclosure96.9% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Eisai across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk